Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Treatment Strategy for Rifampin-Susceptible Tuberculosis.
N Engl J Med. 2023 Mar 9;388(10):873-887. doi: 10.1056/NEJMoa2212537. Epub 2023 Feb 20.
N Engl J Med. 2023.
PMID: 36808186
Clinical Trial.
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial.
Cross GB, Sari IP, Kityo C, Lu Q, Pokharkar Y, Moorakonda RB, Thi HN, Do Q, Dalay VB, Gutierrez E, Balanag VM, Castillo RJ, Mugerwa H, Fanusi F, Kwan P, Chew KL, Paton NI; ROSETTA trial team.
Cross GB, et al. Among authors: dalay vb.
Lancet Infect Dis. 2023 Jul;23(7):847-855. doi: 10.1016/S1473-3099(23)00067-1. Epub 2023 Mar 23.
Lancet Infect Dis. 2023.
PMID: 36966799
Clinical Trial.
Item in Clipboard
Patient-cost survey for tuberculosis in the context of patient-pathway modelling.
Tomeny EM, Mendoza VL, Marcelo DB, Barrameda AJD, Langley I, Abong JM, Dalay VB, Yu CY, Squire SB.
Tomeny EM, et al. Among authors: dalay vb.
Int J Tuberc Lung Dis. 2020 Apr 1;24(4):420-427. doi: 10.5588/ijtld.19.0206.
Int J Tuberc Lung Dis. 2020.
PMID: 32317067
Item in Clipboard
Cite
Cite